Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

KKiniksa Pharmaceuticals International, plc

EconomyAI buildoutMarket MapFundsWatchlist
Log in
K

Kiniksa Pharmaceuticals International, plc

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 3, 2026Megna Michael RCHIEF ACCOUNTING OFFICER4,600Class A Ordinary Share$359.2KSell
Sep 1, 2026Megna Michael RCHIEF ACCOUNTING OFFICER14,600Share Option$1.1MGrant / award
Sep 1, 2026Megna Michael RCHIEF ACCOUNTING OFFICER3,650Restricted Share Unit$285KGrant / award
Sep 1, 2026Megna Michael RCHIEF ACCOUNTING OFFICER5,531Class A Ordinary Share$431.9KTax withholding
Sep 1, 2026Megna Michael RCHIEF ACCOUNTING OFFICER11,496Class A Ordinary Share$897.6KExercise / conversion
Sep 1, 2026Patel Sanj KCHAIRMAN & CEO50,162Restricted Share Unit$3.9MExercise / conversion
Sep 1, 2026Patel Sanj KCHAIRMAN & CEO12,474Restricted Share Unit$974KExercise / conversion
Sep 1, 2026Patel Sanj KCHAIRMAN & CEO240,300Share Option$18.8MGrant / award
Sep 1, 2026Patel Sanj KCHAIRMAN & CEO60,100Restricted Share Unit$4.7MGrant / award
Sep 1, 2026Patel Sanj KCHAIRMAN & CEO30,288Class A Ordinary Share$2.4MTax withholding
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
$78.00Close · Sep 22, 2026